Structure Therapeutics In...

15.81
-1.50 (-8.67%)
At close: Apr 01, 2025, 3:59 PM
15.86
0.29%
After-hours: Apr 01, 2025, 07:24 PM EDT

Structure Therapeutics Ratios Statement

Year FY24 FY23 FY22 FY21 FY20
PE Ratio -43.01 -66.82 -74.14 -100.01K -239.68K
PEG Ratio -8.6 -1 -0.00 n/a n/a
PS Ratio n/a n/a n/a n/a n/a
PB Ratio 6.09 13.22 -33.05 -58.78K -169.35K
P/FCF Ratio -44.68 -73.34 -82.23 -114.04K -266.06K
P/OCF Ratio -45.18 -75.34 -82.51 -118.32K -266.41K
OCF/S Ratio n/a n/a n/a n/a n/a
Debt / Equity Ratio 0.00 0.01 -0.00 -0.01 -0.01
Quick Ratio 24.74 19.14 7.16 12.62 12.64
Current Ratio 24.74 19.14 7.16 12.62 12.64
Asset Turnover n/a n/a n/a n/a n/a
Interest Coverage n/a -7.67 n/a -0.31 n/a
Return on Equity (ROE) n/a n/a n/a n/a n/a
Return on Assets (ROA) n/a n/a n/a n/a n/a
Return on Capital (ROIC) n/a n/a n/a n/a n/a
Dividend Yield n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a